XNCR peer analysis
Xencor (XNCR) against its competitors: price, today's move, 1-year return and market value side by side.
XNCR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADAG Adagene | $2.51 | -6.34% | 30.73% | – |
| CGEN Compugen | $1.98 | -2.94% | 20.00% | $187.56M |
| CLDX Celldex Therapeutics | $29.03 | -3.55% | 11.65% | $2.36B |
| GMAB Genmab | $54.93 | -3.73% | 91.59% | $35.09B |
| IMCR Immunocore | $29.79 | -2.30% | -7.46% | – |
| IMMP Immutep | $3.06 | -8.11% | -92.39% | $22.55M |
| IPHA Innate Pharma | $1.46 | -1.35% | -33.64% | $163.08M |
| MGNX MacroGenics | $2.40 | 0.84% | 50.47% | $152.88M |
| NKTR Nektar | $36.90 | -5.07% | -41.24% | $1.33B |
| NRIX Nurix Therapeutics | $25.70 | -4.09% | 101.13% | – |
| XNCR Xencor | $29.68 | -0.47% | 110.05% | $2.22B |
- XNCR's peers: ADAG (Adagene), CGEN (Compugen), CLDX (Celldex Therapeutics), GMAB (Genmab), IMCR (Immunocore), IMMP (Immutep), IPHA (Innate Pharma), MGNX (MacroGenics).
Updated 2026-11-03 02:49 UTC